Horizon rises as FTC allows Amgen to move forward with $27.8 bln buyout deal

Horizon Therapeutics

01/09/2023 14:24

** Shares of Ireland-based drugmaker Horizon Therapeutics
 HZNP.O  rise 2.76% to $115.85 premarket
    ** Amgen  AMGN.O  shares up 1.11% at $259.19 premarket
    ** The U.S. Federal Trade Commission (FTC) has allowed
drugmaker AMGN to move ahead with its $27.8 bln deal to buy HZNP
    ** The companies anticipate being able to close the
acquisition in early Q4 2023
    ** FTC filed a lawsuit in May aimed at stopping the
transaction, but suspended its challenge in late August
    ** Up to last close, HZNP stock down marginally, AMGN down
2.40% YTD

 (Reporting by Sriparna Roy in Bengaluru)
 ((Sriparna.Roy@thomsonreuters.com;))